INFANRIX Israel - English - Ministry of Health

infanrix

glaxo smith kline (israel) ltd - diphtheria toxoid; filamentous haemagglutinin (fha); pertactin; pertussis toxoid (pt); tetanus toxoid - suspension for injection - diphtheria toxoid nlt 30 iu; tetanus toxoid nlt 40 iu; pertactin 8 mcg / 0.5 ml; filamentous haemagglutinin (fha) 25 mcg / 0.5 ml; pertussis toxoid (pt) 25 mcg / 0.5 ml - bacterial and viral vaccines, combined - infanrix is indicated as a booster dose for children 15 months to 7 years of age who have previously been immunised with three or four doses of either dtpa vaccine or diphtheria, tetanus and whole-cell pertussis (dtpw) vaccine. active primary immunisation against diphteria, tetanus and pertussis from the age 2 months onward.

None Each 0.5 mL contains: Diphteria Toxoid 25 lf > 30 IU Tetanus Toxoid 5.5 Lf > 60 IU B. Pertussis (Whole Cell) 16 IOU Philippines - English - FDA (Food And Drug Administration)

none each 0.5 ml contains: diphteria toxoid 25 lf > 30 iu tetanus toxoid 5.5 lf > 60 iu b. pertussis (whole cell) 16 iou

glovax biotech corp.; distributor: glovax biotech corp. - diphtheria, tetanus, pertussis hepatitis b recombinant and haemophilus influenza b type (hib) vaccine (see formulation on reverse side) - suspension for injection (im) - each 0.5 ml contains: diphteria toxoid 25 lf > 30 iu tetanus toxoid 5.5 lf > 60 iu b. pertussis (whole cell) 16 iou >

Infanrix (DTPa) inj. susp. i.m. pre-filled syr. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

infanrix (dtpa) inj. susp. i.m. pre-filled syr.

glaxosmithkline biologicals sa-nv - tetanus toxoid >= 40 iu/dose; bordetella pertussis toxoid (pt) 25 µg/dose; bordetella pertussis filamentous hemagglutinin (fha) 25 µg/dose; bordetella pertussis pertactin 8 µg/dose; diphtheria toxoid (dt) >= 30 iu/dose - suspension for injection in pre-filled syringe - diphteria toxoid, adsorbed; tetanus toxoid adsorbed; bordetella pertussis antigen, adsorbed - pertussis, purified antigen, combinations with toxoids

Boostrix Polio inj. susp. i.m. pre-filled syr. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

boostrix polio inj. susp. i.m. pre-filled syr.

glaxosmithkline biologicals sa-nv - bordetella pertussis filamentous hemagglutinin (fha) 8 µg/dose; diphtheria toxoid (dt) >= 2 iu/dose; poliovirus type 3 (inactivated) 32 d-antigen u/1 dose; pertactin (bordetella pertussis antigen) 2,5 µg/dose; bordetella pertussis toxoid (pt) 8 µg/dose; tetanus toxoid >= 20 iu/dose; poliovirus type 2 (inactivated) 8 d-antigen u/1 dose; poliovirus type 1 (inactivated) 40 d-antigen u/1 dose - suspension for injection in pre-filled syringe - diphteria toxoid, adsorbed; poliomyelitis virus, inactivated; tetanus toxoid adsorbed; bordetella pertussis antigen, proteins - diphtheria-pertussis-poliomyelitis-tetanus

Infanrix+Hib 0,5 ml/dose inj. susp. (pwdr. + susp.) i.m. pre-filled syr. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

infanrix+hib 0,5 ml/dose inj. susp. (pwdr. + susp.) i.m. pre-filled syr. vial

glaxosmithkline biologicals sa-nv - conjugate of haemophilus influenzae type b capsular polysaccharide and tetanus toxoid 30 µg - 50 µg; bordetella pertussis filamentous hemagglutinin (fha) 25 µg/dose; diphtheria toxoid (dt) >= 30 iu/dose; bordetella pertussis pertactin 8 µg/dose; tetanus toxoid >= 40 iu/dose; bordetella pertussis toxoid (pt) 25 µg/dose - powder and suspension for suspension for injection - diphteria antigen, adsorbed; haemophilus influenzae type b polysaccharides, conjugated to tetanus toxoid; tetanus toxoid adsorbed; bordetella pertussis antigen, proteins - hemophilus influenzae b, combinations with toxoids

Infanrix (DTPa) inj. susp. i.m. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

infanrix (dtpa) inj. susp. i.m. vial

glaxosmithkline biologicals sa-nv - tetanus toxoid >= 40 iu/dose; bordetella pertussis toxoid (pt) 25 µg/dose; bordetella pertussis filamentous hemagglutinin (fha) 25 µg/dose; bordetella pertussis pertactin 8 µg/dose; diphtheria toxoid (dt) >= 30 iu/dose - suspension for injection in pre-filled syringe - diphteria antigen, adsorbed; tetanus toxoid adsorbed; bordetella pertussis - pertussis, purified antigen, combinations with toxoids

Boostrix inj. susp. i.m. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

boostrix inj. susp. i.m. vial

glaxosmithkline biologicals sa-nv - bordetella pertussis filamentous hemagglutinin (fha) 8 µg/dose; diphtheria toxoid (dt) >= 2 iu/dose; bordetella pertussis toxoid (pt) 8 µg/dose; bordetella pertussis pertactin 2,5 µg/dose; tetanus toxoid >= 20 iu/dose - suspension for injection - diphteria antigen, adsorbed; tetanus toxoid adsorbed; bordetella pertussis - pertussis, purified antigen, combinations with toxoids

Boostrix inj. susp. i.m. pre-filled syr. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

boostrix inj. susp. i.m. pre-filled syr.

glaxosmithkline biologicals sa-nv - bordetella pertussis filamentous hemagglutinin (fha) 8 µg/dose; diphtheria toxoid (dt) >= 2 iu/dose; bordetella pertussis toxoid (pt) 8 µg/dose; bordetella pertussis pertactin 2,5 µg/dose; tetanus toxoid >= 20 iu/dose - suspension for injection - diphteria antigen, adsorbed; tetanus toxoid adsorbed; bordetella pertussis - pertussis, purified antigen, combinations with toxoids

Triaxis inj. susp. s.c./i.m. pre-filled syr. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

triaxis inj. susp. s.c./i.m. pre-filled syr.

sanofi pasteur europe s.a. - bordetella pertussis toxoid (pt) ; diphtheria toxoid (dt) >= 2 iu/0,5 ml; bordetella pertussis purified fimbrial agglutinogens 2 and 3 (fim) ; bordetella pertussis pertactin ; bordetella pertussis filamentous hemagglutinin (fha) ; aluminium phosphate 1,5 mg/0,5 ml; tetanus toxoid >= 20 iu/0,5 ml - suspension for injection in pre-filled syringe - tetanus toxoid adsorbed; diphteria antigen, adsorbed; bordetella pertussis antigen, adsorbed - pertussis, purified antigen, combinations with toxoids

Boostrix Polio inj. susp. i.m. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

boostrix polio inj. susp. i.m. vial

glaxosmithkline biologicals sa-nv - bordetella pertussis filamentous hemagglutinin (fha) 8 µg/dose; diphtheria toxoid (dt) >= 2 iu/dose; poliovirus type 3 (inactivated) 32 d-antigen u/1 dose; pertactin (bordetella pertussis antigen) 2,5 µg/dose; bordetella pertussis toxoid (pt) 8 µg/dose; tetanus toxoid >= 20 iu/dose; poliovirus type 2 (inactivated) 8 d-antigen u/1 dose; poliovirus type 1 (inactivated) 40 d-antigen u/1 dose - suspension for injection - diphteria antigen, adsorbed; poliomyelitis virus; tetanus toxoid adsorbed; bordetella pertussis antigen, proteins - diphtheria-pertussis-poliomyelitis-tetanus